Canbud Distribution Corp. (
CSE.CBDX,
Forum) has announced that its wholly-owned subsidiary, Molecular Science Corp. (MSC) – a leading GMP analytical services company – received its Dealer's License from Health Canada on July 30, 2021.
As a result, MSC has become one of very few organizations able to work with Psilocybin with Health Canada approval
This significant milestone expands MSC's current licensed capabilities to include the possession, sale/provision, transportation, and testing of controlled substances including Psilocybin, Ketamine, and N-3,4 Methylenedioxyamphetamine.
Obtaining this license enables MSC to rapidly integrate and establish itself as one of leaders in the emerging analytical support network that will be integral to product safety and quality as demand grows for these substances of interest in Canada and internationally.
Full story
here.
About Canbud
Canbud Distribution Corp. is an early-stage, vertically-integrated science and technology company focused on the global hemp markets inclusive of plant based, psychedelic pharmaceutical and non-psychedelic nutraceutical, and hemp cannabinoids (CBD) verticals. Currently the company, through its subsidiaries, holds three industrial hemp licences for the purposes of supplying the global market with medicinal and wellness cannabidiol and other cannabinoid-based products.
New to investing in Cannabis? Check out Stockhouse tips on How to Invest in Cannabis Stocks and some of our Top Cannabis Stocks.
For more of the latest info on Cannabis, check out the Cannabis Trending News hub on Stockhouse.
FULL DISCLOSURE: Canbud Distribution Corp. is a client of Stockhouse Publishing.